Pulmonary Arterial Hypertension Clinical Trials in Philadelphia, Pennsylvania

5 studies are recruiting for pulmonary arterial hypertension in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

   The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP compared with placebo on exercise capacity in adults with PAH.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   USA006, Philadelphia, Pennsylvania

   Locations

   26 in total

   Run by

   Insmed Incorporated

   See if you can join NCT07481981 on ClinicalTrials.gov

2. Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

   This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   120 in total

   Run by

   Gossamer Bio USA, Inc.

   See if you can join NCT06274801 on ClinicalTrials.gov

3. Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

   The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to <18 years of age with PAH World Health Organization (WHO) Group 1 on standard of care (SoC). There is no formal hypothesis.

   Stage

   Phase 2

   Ages

   1 to 17

   Site

   Children's Hospital of Philadelphia (CHOP) ( Site 1608), Philadelphia, Pennsylvania

   Locations

   35 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT05587712 on ClinicalTrials.gov

4. Pulmonary Hypertension Association Registry

   The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

   Stage

   Not phased

   Ages

   0 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   52 in total

   Run by

   Pulmonary Hypertension Association, Inc.

   See if you can join NCT04071327 on ClinicalTrials.gov

5. Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

   Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe t…

   Stage

   Not phased

   Ages

   0 to 21

   Site

   Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

   Locations

   14 in total

   Run by

   New York Medical College

   See if you can join NCT02249923 on ClinicalTrials.gov